Skip to main content
The University of Arizona Wordmark Line Logo White
Stories & Features Announcements Calendar Leadership Updates Event Planning Room Scheduling Café Bolo Directories IT Support Classroom Support Planning & Facilities
The University of Arizona Health Sciences | Home
Subscribe
Support
home home

Main navigation

  • Overview Senior Leadership Academic Leadership Executive Leadership Annual Report Mission, Values, History Support
  • Overview College of Health Sciences College of Medicine – Phoenix College of Medicine – Tucson College of Nursing Mel and Enid Zuckerman College of Public Health R. Ken Coit College of Pharmacy
  • Research Administration Research Awards and Grants
  • Clinical
  • Overview Community Engagement Alliance Corporate and Community Relations Health and Humanities Rural Health Student Engagement and Career Advancement
  • Overview Aegis Consortium All of Us Research Program Arizona Area Health Education Centers Arizona Simulation Technology & Education Center Asthma & Airway Disease Research Center Center for Accelerated Biomedical Innovation Center for Advanced Molecular & Immunological Therapies Center for Biomedical Informatics & Biostatistics Center for Disparities in Diabetes, Obesity & Metabolism Center for Innovation in Brain Science Center for Sleep, Circadian & Neuroscience Research Clinical & Translational Sciences Research Center Comprehensive Center for Pain & Addiction Health Sciences SensorLab One Health University of Arizona Cancer Center
  • All News Stories Videos The Healthy Dose Blog News Releases In The Media Media Resources Office of Communications
  1. Home
  2. News
  3. Cholesterol Buildup Brain Presents New Target Reduce Dementia Risk Stroke 0

Pharmather Inc. Licenses UArizona Parkinson’s Disease Treatment

Nov. 10, 2020

Researchers at the University of Arizona College of Medicine – Tucson have developed a method of using ketamine in the treatment of Parkinson’s disease. The university has entered into an exclusive licensing agreement with Pharmather Inc., a subsidiary of Newscope Capital Corporation, for the development and commercialization of the method.

BizTucson
Thumbnail

Immunotherapy Cancer Vaccine Trial Offers Patients New Hope

Nov. 9, 2020

Researchers used a patient’s cancer cells to teach her immune system how to recognize and destroy the cancer, revealing an option for successfully treating others.

Read more
Image
Alicia Allen, PhD, MPH

Dr. Alicia Allen Awarded Prestigious NIH ‘New Innovator Award’

Nov. 9, 2020
Read more
Image

UArizona Health Sciences Joint Study Finds Dual Inhibitor Strategy May Be Key to Sustainable COVID-19 Treatment

Nov. 9, 2020

Researchers in the College of Pharmacy say compounds targeting proteins involved in viral replication may further drug development for treating COVID-19.

Read more
Image

Personalized Cancer Vaccine Clinical Trial to Expand Following Promising Early Results

Nov. 9, 2020

A study investigating a personalized cancer vaccine has reported a 50% response rate for patients with head and neck cancer in its preliminary data.

Read more
Image

Pharma Company Licenses UArizona Method for Treating Parkinson's Disease with Ketamine

Nov. 9, 2020

In pre-clinical studies, researchers found that low-dose ketamine infusions can improve pain, depression and levodopa-induced dyskinesia in Parkinson's patients.

Read more

Compounds that Inhibit Coronavirus Entry, Replication in Human Cells Identified

Nov. 9, 2020

A new study by researchers at the University of South Florida Health Morsani College of Medicine and the University of Arizona College of Pharmacy, offers insight into designing antiviral drugs against COVID-19.

Tribune (India)

Should You Host a Thanksgiving Gathering? Here's What AZ Experts Say About Holiday Safety

Nov. 9, 2020

To figure out how holiday gatherings can be adapted so that possible transmission of COVID-19 is less likely, the Arizona Republic spoke with Dr. Kelly Reynolds, an expert on disease transmission and professor at UA’s Mel and Enid Zuckerman College of Public Health.

The Arizona Republic

Coronavirus in Arizona Could Reach ‘Crisis Point’ After Thanksgiving, Expert Warns

Nov. 9, 2020

As coronavirus cases grow in Arizona, the state could reach a “crisis point” after Thanksgiving, one expert recently warned. “I don’t see us reaching any particular crisis point before Thanksgiving,” Dr. Joe Gerald, an associate professor with the University of Arizona’s Zuckerman College of Public Health, told the Arizona Daily Star.

Fox News

Arizona Sen.-Elect Mark Kelly has Announced His 13-Person Transition Team

Nov. 9, 2020

Joe Gerald, an associate professor at the University of Arizona's Mel and Enid Zuckerman College of Public Health and an epidemiologist working on modeling the COVID-19 pandemic, has been named to Arizona Sen.-elect Mark Kelly's 13-person bipartisan transition team.

KTAR-FM Phoenix

Pagination

  • « First First page
  • ‹ Previous Previous page
  • …
  • 453
  • 454
  • 455
  • 456
  • 457
  • 458
  • 459
  • 460
  • 461
  • …
  • Next › Next page
  • Last » Last page
The University of Arizona Health Sciences | Home

Health Sciences

  • About
  • Academics
  • Clinical Care
  • Outreach

News

  • Stories
  • Healthy Dose Blog
  • News Releases
  • In The Media
  • Media Resources
  • Videos

Internal Resources

  • Stories & Features
  • Announcements
  • Calendar
  • Leadership Updates
  • Honors and Awards
  • Event Planning
  • Room Scheduling
  • Café Bolo
  • El Mirador Project
  • IT Support
  • Classroom Support
  • Planning and Facilities
  • Photo Galleries
  • Directories

Connect

  • Facebook
  • YouTube
  • Instagram
  • LinkedIn
  • X, formerly Twitter

We respectfully acknowledge the University of Arizona is on the land and territories of Indigenous peoples. Today, Arizona is home to 22 federally recognized tribes, with Tucson being home to the O’odham and the Yaqui. The University strives to build sustainable relationships with sovereign Native Nations and Indigenous communities through education offerings, partnerships, and community service.


University Information Security and Privacy

© 2025 The Arizona Board of Regents on behalf of The University of Arizona.